The explorative clinical trial of a medicine for treatment of CIN (Cervical Intraepithelial Neoplasia) using lactobacillus to HPV16 positive CIN 2. - The explorative clinical trial of a medicine for treatment of CIN using lactobacillus to CIN2.

The University of Tokyo Hospital Department of Obstetrics & Gynecology0 个研究点目标入组 40 人开始时间: 2013年12月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Person who has obviously received prohibition of using together medicine (treatment) that causes person and immune suppression that has disease that abnormality is found in immune function 2) patients of SCC in cervical cytology. 3) whom hope for laser ablation or conization of the cervix 4) patients with serious acute illness 5) patients that there are previous histories of hypersensitivity in lactobacillus content food (yogurt etc.) and preparation of lactobacillus 6) patients who has allergy for milk 7) pregnant or expected to be pregnant 8) breast feeding mother 9) whom administered other trial drugs within three months before initiation of this trial study 10) whom administered this medicine 11) whom the investigator think inappropriate as a candidate.

发起方

The University of Tokyo Hospital Department of Obstetrics & Gynecology